Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study-Reference-Cited by-同舟云学术

Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study

Published:2017-07 Issue:10093 Volume:390 Page:490-499
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Li Linxin,Geraghty Olivia C,Mehta Ziyah,Rothwell Peter M

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Aspirin use among adults in the U.S. Results of a national survey;Williams;Am J Prev Med,2015

2. Aspirin taking in a south Wales county;Elwood;Br J Cardiol,2011

3. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association;Kernan;Stroke,2014

4. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute;Smith;Circulation,2006

5. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials;Baigent;Lancet,2009

Cited by 312 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limits of pre-endoscopic scoring systems in geriatric patients with upper gastrointestinal bleeding;Scientific Reports;2024-08-30

2. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

3. Proton Pump Inhibitor Prescription in Nursing Home Residents: Prevalence, Appropriateness, and Associated Factors—A Secondary Data Analysis from Three German Regions and the Impact of Guideline Recommendations;Pharmaceuticals;2024-08-17

4. Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder Cancer;Nano Letters;2024-08-13

5. Transfusion and clinical outcomes after percutaneous coronary intervention;Scientific Reports;2024-08-09